BioNext Opportunity Hub
Explore Selected Life Sciences Opportunities
BioNext provides access to a curated pipeline of innovative life sciences organizations seeking strategic partners, investors and industry collaborators.
The opportunities presented in this section cover a range of areas, including diagnostics, precision medicine, immunology, oncology, digital health, medtech and therapeutic platforms.
Our objective is to give qualified partners early visibility on differentiated technologies and assets that may be relevant for licensing, investment, co-development, validation, commercialization or broader strategic collaboration.
DiagnosticsImmunologyPrecision Medicine
Personalizing Immunosuppression in Kidney Transplant Care
A CE-marked precision medicine IVD platform designed to support personalization of immunosuppressive therapy in kidney transplant patients. The test assesses how a patient’s immune cells respond…
Explore This Opportunity
ImmunologyOncologyTherapeutic Platforms
Built-In Immune Activation for Next-Generation Immunotherapies and Vaccines
A novel fully synthetic immunotherapy platform designed to enhance both T- and B-cell responses through targeted antigen delivery and built-in immune activation. The technology is intended to…
Explore This Opportunity
DiagnosticsImmunology
Next-Generation Drug Allergy Diagnostics
A silicon-photonics-based IVD platform enabling rapid, automated and highly sensitive detection of immune responses from serum samples. The technology combines label-free optical biosensing,…
Explore This Opportunity
OncologyTherapeutic Platforms
First-in-Class RNA-Targeted Oncology Asset
A clinical-stage oncology opportunity is developing a first-in-class small-molecule approach designed to modulate oncogenic protein expression by targeting structured regulatory elements within…
Explore This Opportunity
DiagnosticsPrecision Medicine
Ultra-Sensitive Multiplex Biomarker Quantification
Seeking strategic partners for a next-generation digital biomarker detection platform based on individual nanoparticle counting. The technology enables ultra-sensitive, multiplexed quantification…
Explore This Opportunity
MedTech
Next-Generation Visual Simulation for IOLs
Novel visual simulation technology that enables patients to experience and compare the real-world visual outcomes of different premium intraocular lenses before cataract or presbyopia surgery.…
Explore This Opportunity
Digital Health
Real-Time Cognitive and Emotional AI
A neuroscience-based cognitive and emotional AI platform that interprets biometric, behavioral and contextual signals in real time to understand human mental and emotional states. The technology…
Explore This Opportunity
DiagnosticsPrecision Medicine
Sensitive Multi-Omics Solutions for Translational Research
A molecular profiling and bioinformatics platform enabling highly sensitive analysis of RNA, DNA, epigenetic markers, microbiome signatures and cell-free nucleic acids. The technology supports…
Explore This Opportunity
Would you like your technology to be featured in our BioNext Opportunity Hub?
If you are a life sciences company seeking visibility with potential investors, strategic partners or industry collaborators, we would be happy to evaluate whether your technology or asset could be included in our curated opportunities marketplace.
Contact the BioNext team